274 related articles for article (PubMed ID: 20644030)
21. Sirolimus Gel Treatment vs Placebo for Facial Angiofibromas in Patients With Tuberous Sclerosis Complex: A Randomized Clinical Trial.
Wataya-Kaneda M; Ohno Y; Fujita Y; Yokozeki H; Niizeki H; Ogai M; Fukai K; Nagai H; Yoshida Y; Hamada I; Hio T; Shimizu K; Murota H
JAMA Dermatol; 2018 Jul; 154(7):781-788. PubMed ID: 29800026
[TBL] [Abstract][Full Text] [Related]
22. Topical everolimus for facial angiofibromas in the tuberous sclerosis complex. A first case report.
Dill PE; De Bernardis G; Weber P; Lösch U
Pediatr Neurol; 2014 Jul; 51(1):109-13. PubMed ID: 24810875
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and Safety of Topical Sirolimus Therapy for Facial Angiofibromas in the Tuberous Sclerosis Complex : A Randomized Clinical Trial.
Wataya-Kaneda M; Nakamura A; Tanaka M; Hayashi M; Matsumoto S; Yamamoto K; Katayama I
JAMA Dermatol; 2017 Jan; 153(1):39-48. PubMed ID: 27837201
[TBL] [Abstract][Full Text] [Related]
24. Sustained clinical effectiveness and favorable safety profile of topical sirolimus for tuberous sclerosis - associated facial angiofibroma.
Salido R; Garnacho-Saucedo G; Cuevas-Asencio I; Ruano J; Galán-Gutierrez M; Vélez A; Moreno-Giménez JC
J Eur Acad Dermatol Venereol; 2012 Oct; 26(10):1315-8. PubMed ID: 21834948
[TBL] [Abstract][Full Text] [Related]
25. Unilateral facial angiofibromas--a segmental form of tuberous sclerosis.
McGrae JD; Hashimoto K
Br J Dermatol; 1996 Apr; 134(4):727-30. PubMed ID: 8733380
[TBL] [Abstract][Full Text] [Related]
26. A Review of Topical Sirolimus for the Treatment of Facial Angiofibromas in Tuberous Sclerosis Complex.
Dao DD; Pixley JN; Akkurt ZM; Feldman SR
Ann Pharmacother; 2024 Apr; 58(4):428-433. PubMed ID: 37386842
[TBL] [Abstract][Full Text] [Related]
27. Topical rapamycin therapy to alleviate the cutaneous manifestations of tuberous sclerosis complex: a double-blind, randomized, controlled trial to evaluate the safety and efficacy of topically applied rapamycin.
Koenig MK; Hebert AA; Roberson J; Samuels J; Slopis J; Woerner A; Northrup H
Drugs R D; 2012 Sep; 12(3):121-6. PubMed ID: 22934754
[TBL] [Abstract][Full Text] [Related]
28. Ambient-stable topical rapamycin cream is effective in treating angiofibromas in tuberous sclerosis complex.
Hong CH; Lee CH
Br J Dermatol; 2023 Oct; 189(5):507-508. PubMed ID: 37672663
[No Abstract] [Full Text] [Related]
29. Topical rapamycin combined with calcitriol in treating angiofibromas in tuberous sclerosis complex.
Lee CH
Br J Dermatol; 2020 Oct; 183(4):604-606. PubMed ID: 32338383
[No Abstract] [Full Text] [Related]
30. Topical rapamycin in the treatment of facial angiofibromas in tuberous sclerosis: a systematic review based on evidence.
Cortell Fuster C; Martínez Gómez MA; Cercós Lleti AC; Climente Martí M
J Dermatolog Treat; 2022 Jun; 33(4):1804-1810. PubMed ID: 33821748
[TBL] [Abstract][Full Text] [Related]
31. Topical sirolimus for the treatment of angiofibromas in tuberous sclerosis.
Cinar SL; Kartal D; Bayram AK; Canpolat M; Borlu M; Ferahbas A; Per H
Indian J Dermatol Venereol Leprol; 2017; 83(1):27-32. PubMed ID: 27643542
[TBL] [Abstract][Full Text] [Related]
32. Rapamycin therapy for renal, brain, and skin lesions in a tuberous sclerosis patient.
Micozkadioglu H; Koc Z; Ozelsancak R; Yildiz I
Ren Fail; 2010; 32(10):1233-6. PubMed ID: 20954988
[TBL] [Abstract][Full Text] [Related]
33. A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin.
Sigg N; Fouquet J; Morin D; Farges D; Vrignaud S; Martin L
Ann Dermatol Venereol; 2023 Dec; 150(4):270-273. PubMed ID: 37821253
[TBL] [Abstract][Full Text] [Related]
34. Acneiform Lesion: Importance of Detailed Skin Examination.
Samanta D
Indian J Pediatr; 2016 May; 83(5):485-6. PubMed ID: 26558921
[No Abstract] [Full Text] [Related]
35. Photodynamic therapy in a patient with facial angiofibromas due to tuberous sclerosis complex.
Shi M; He S; Chen P; Li Q; Zhu M; Guo J; Jiang L; Wang Q; Peng X; Li S; Li C; Zeng K
Photodiagnosis Photodyn Ther; 2019 Dec; 28():183-185. PubMed ID: 31398516
[TBL] [Abstract][Full Text] [Related]
36. [Successful treatment of facial angiofibromas with local sirolimus in childhood in Bourneville-Pringle disease].
Bottyán K; Kemény L; Csoma ZR
Orv Hetil; 2019 Mar; 160(13):516-520. PubMed ID: 30907099
[TBL] [Abstract][Full Text] [Related]
37. Unilateral multiple facial angiofibromas: a mosaic form of tuberous sclerosis.
Silvestre JF; Bañuls J; Ramón R; Guijarro J; Botella R; Betlloch I
J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):127-9. PubMed ID: 10863238
[TBL] [Abstract][Full Text] [Related]
38. Facial angiofibromas treated with topical rapamycin: an excellent choice with fast response.
Truchuelo T; Díaz-Ley B; Ríos L; Alcántara J; Jaén P
Dermatol Online J; 2012 Jan; 18(1):15. PubMed ID: 22301052
[TBL] [Abstract][Full Text] [Related]
39. The efficacy and safety of topical rapamycin-calcitriol for facial angiofibromas in patients with tuberous sclerosis complex: a prospective, double-blind, randomized clinical trial.
Chen PL; Hong JB; Shen LJ; Chen YT; Wang SJ; Liao YH
Br J Dermatol; 2020 Oct; 183(4):655-663. PubMed ID: 32064596
[TBL] [Abstract][Full Text] [Related]
40. Successful topical rapamycin treatment for facial angiofibromata in two children.
Pynn EV; Collins J; Hunasehally PR; Hughes J
Pediatr Dermatol; 2015; 32(3):e120-3. PubMed ID: 25790347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]